School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Keith Delman MD

  • Department of Surgery
    Professor
  • (404) 251-8793
  • kdelman@emory.edu
Head shot of Keith Delman

Overview

Dr. Delman's clinical practice focuses on treating complex cutaneous oncology, including melanoma, sarcoma, adnexal tumors of the skin, and Merkel cell carcinoma. As co-chair of Winship Cancer Institute's Melanoma Working Group/Multi-Disciplinary Tumor Board from 2006-2020, and now Winship's Melanoma Disease Team Leader, he oversees the multidisciplinary care of nearly half of all patients diagnosed with melanoma in the state of Georgia.

In 2009, Dr. Delman and Emory urologist Dr. Viraj Master were the first team in the world to perform minimally invasive inguinofemoral lymphadenectomy for melanoma. Since then, they have taught the procedure to surgeons from around the world.

Dr. Delman's achievements as an educator include: serving as program director of the Emory general surgery residency from 2011-2020; assisting in the establishment of the Emory Surgery Global Surgery Program in 2011, one of the first American Board of Surgery-approved international surgical training experiences; spearheading the 2012 renovation of the Department of Surgery's surgical education offices in Emory University Hospital to include such technologies as a dedicated 24 hour simulation lab; and transitioning the Carlos and Davis Center for Surgical Anatomy and Technique (CSAT) from its primarily print media platform to a digital, electronic format to disseminate educational materials related to developing knowledge of surgical anatomy. He then served as director of CSAT from 2012-2022.

Academic Appointment

  • Professor of Surgery, Department of Surgery, Emory University School of Medicine

Education

Degrees

  • MD from S.U.N.Y. at Stony Brook School of Medicine
  • BA from Cornell University

Research

Focus

  • Clinical and translational research involving tumors of the skin and soft tissue.

Publications

  • The Landmark Series: Melanoma and Adjuvant Therapy.
    Ann Surg Oncol Volume: 32 Page(s): 3212 - 3215
    05/01/2025 Authors: Lowe MC; Delman KA; Ollila DW
  • Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma.
    Ann Surg Oncol Volume: 32 Page(s): 1429 - 1442
    03/01/2025 Authors: Bartlett EK; O'Donoghue C; Boland G; Bowles T; Delman KA; Hieken TJ; Moncrieff M; Wong S; White RL; Karakousis G
  • The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
    Urol Case Rep Volume: 57 Page(s): 102875
    11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA
  • Standard Setting for the CGSO Qualifying Examination: A Structured Approach Setting a Meaningful Standard.
    Ann Surg Oncol Volume: 31 Page(s): 3569 - 3571
    06/01/2024 Authors: Eng OS; Delman KA; Barry CL; Dineen SP; Larkin AC
  • Discussion.
    J Am Coll Surg Volume: 238 Page(s): 516 - 519
    04/01/2024
  • Piloting a National Curricular Resource for the Transition to Surgical Residency: Characteristics of Participating Schools and Their Students.
    J Surg Educ Volume: 81 Page(s): 344 - 352
    03/01/2024 Authors: Jayas A; Sachdeva AK; Delman KA; Kabaker AS; Blair PG; Overton R; Grbic D; Andriole DA
  • Utilizing Simulation to Evaluate Robotic Skill Acquisition and Learning Decay.
    Surg Laparosc Endosc Percutan Tech Volume: 33 Page(s): 317 - 323
    06/01/2023 Authors: Liu S; Watkins K; Hall CE; Liu Y; Lee S-H; Papandria D; Delman KA; Srinivasan J; Patel A; Davis SS
  • HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
    J Virol Volume: 97 Page(s): e0167022
    04/27/2023 Authors: Mallarino-Haeger C; Pino M; Viox EG; Pagliuzza A; King CT; Nguyen K; Harper JL; Aldrete SDM; Cervasi B; Delman KA
  • Discussion.
    J Am Coll Surg Volume: 236 Page(s): 934 - 936
    04/01/2023
  • Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
    Ann Surg Oncol Volume: 29 Page(s): 5910 - 5920
    09/01/2022 Authors: Jakub JW; Lowe M; Howard JH; Farma JM; Sarnaik A; Tuttle T; Neuman HB; Ariyan CE; Uppal A; Trocha S
  • How We Do It: Remediation Pathways in a Surgical Simulation Curriculum for Competency Improvement.
    Am Surg Volume: 88 Page(s): 1766 - 1772
    08/01/2022 Authors: Lovasik BP; Fay KT; Hinman JM; Delman KA; Srinivasan JK; Santore MT
  • ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II.
    Ann Surg Oncol
    05/12/2022 Authors: Jakub JW; Lowe M; Harrison Howard J; Farma JM; Sarnaik A; Tuttle T; Neuman HB; Ariyan CE; Uppal A; Trocha S
  • Neuroendocrine Gene Expression in Primary Melanoma Tumors of Obese and Normal-Weight Patients
    Volume: 29 Page(s): 464 - 464
    05/01/2022 Authors: Harrell CS; Bhasin M; Baecher KM; Dwivedi B; Delman KA; Lowe MC
  • When Is Surgery the Optimal Adjuvant Treatment?
    JAMA Surg Volume: 157 Page(s): 343
    04/01/2022 Authors: Delman KA; Wong SL
  • Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience.
    Am Surg Volume: 88 Page(s): 480 - 488
    03/01/2022 Authors: Baecher KM; Turgeon MK; Medin CR; Mahendran G; Flakes TM; Delman KA; Lowe MC
  • ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience.
    Ann Surg Oncol Volume: 29 Page(s): 804 - 805
    02/01/2022 Authors: Carr MJ; Sun J; DePalo D; Rothermel LD; Song Y; Straker RJ; Baecher K; Louie RJ; Stahlie EHA; Wright GP
  • Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard.
    Ann Surg Oncol Volume: 29 Page(s): 758 - 759
    02/01/2022 Authors: Delman KA; Mason MC; Lowe MC
  • Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
    Volume: 29 Page(s): 791 - 801
    02/01/2022 Authors: Carr MJ; Sun J; DePalo D; Rothermel LD; Song Y; Straker RJ; Baecher K; Louie RJ; Stahlie EHA; Wright GP
  • Resident Readiness for Senior Level Decision Making: Identifying the Domains for Formative Assessment and Feedback.
    J Surg Educ Volume: 79 Page(s): 1124 - 1131
    01/01/2022 Authors: Park KM; Gesbeck MM; Alseidi AA; Park YS; Sullivan ME; Salcedo ES; Blair PG; Liscum K; Sachdeva AK; ACS SRRA Research Group
  • Relationship between burnout and mistreatment: Who plays a role?
    Am J Surg Volume: 222 Page(s): 1060 - 1065
    12/01/2021 Authors: Baker S; Gleason F; Lovasik B; Sandhu G; Cortez A; Hildreth A; Cooper A; Simmons J; Delman KA; Lindeman B
  • In Search of a More Accurate Nodal Staging System for Melanoma: Should We Sacrifice Simplicity?
    JAMA Surg Volume: 156 Page(s): e214306
    11/01/2021 Authors: Baecher K; Delman K; Lowe M
  • The Impact of Obesity on Surgically Treated Locoregional Melanoma.
    Ann Surg Oncol Volume: 28 Page(s): 6140 - 6151
    10/01/2021 Authors: Harrell Shreckengost CS; Tariq M; Farley CR; Zhang C; Delman KA; Kudchadkar RR; Lowe MC
  • Non-technical skill assessments across levels of US surgical training.
    Surgery Volume: 170 Page(s): 713 - 718
    09/01/2021 Authors: Pradarelli JC; Gupta A; Hermosura AH; Murayama KM; Delman KA; Shabahang MM; Havens JM; Lipsitz S; Smink DS; Yule S
  • Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
    PLoS Pathog Volume: 17 Page(s): e1009825
    08/01/2021 Authors: Pino M; Pereira Ribeiro S; Pagliuzza A; Ghneim K; Khan A; Ryan E; Harper JL; King CT; Welbourn S; Micci L
  • Letter Regarding Editorial by Samuel Zagarella.
    Am J Dermatopathol Volume: 43 Page(s): 539 - 541
    07/01/2021 Authors: Faries MB; Ascierto PA; Blank C; Cochran AJ; Delman K; Gyorki D; Haanen J; Hamid O; Han D; Karakousis G
  • A longitudinal cadaver-based simulation curriculum creates sustainable increases in resident confidence and exposure to fundamental techniques: Results of a 5-year program evaluation.
    Am J Surg Volume: 222 Page(s): 104 - 110
    07/01/2021 Authors: Lovasik BP; Kim SC; Wang VL; Fay KT; Santore MT; Delman KA; Srinivasan JK
  • Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 232 Page(s): 524 - 525
    04/01/2021 Authors: Delman KA
  • Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis Invited Commentary
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 232 Page(s): 431 - 432
    04/01/2021 Authors: Delman KA
  • Invited Commentary.
    J Am Coll Surg Volume: 232 Page(s): 524 - 525
    04/01/2021 Authors: Delman KA
  • Invited Commentary.
    J Am Coll Surg Volume: 232 Page(s): 431 - 432
    04/01/2021 Authors: Delman KA
  • Clinical Case-Conference Blogs: Integrating Clinical Librarians to Enhance Resident Education and Enforce ACGME Competencies.
    Med Sci Educ Volume: 31 Page(s): 375 - 380
    04/01/2021 Authors: Lovasik BP; Haydek JP; Rutledge H; Lawson E; Buchter DS; Delman KA; Dressler DD
  • Safety of Talimogene Laherparepvec in the Geriatric Melanoma Patient: A Multi-Institutional Experience
    Volume: 28 Page(s): S107 - S108
    02/01/2021 Authors: Johnson J; Louie RJ; Carr MJ; Baecher K; Collichio F; Lowe MC; Sarnaik AA; Delman KA; Zager JS; Ollila DW
  • Trainee Utilization of the SCORE Curriculum is Associated With Improved ABSITE Performance: A Multi-institutional Study.
    J Surg Educ Volume: 78 Page(s): e196 - e200
    01/01/2021 Authors: McGaha P; Klingensmith ME; Cross A; Stewart K; Grimes A; Horton M; Kowdley G; Patel K; Galante J; Wise PE
  • APDS Consensus Statement: Ideal Senior Medical Student Experiences for Preparedness for General Surgery Internship.
    J Surg Educ Volume: 78 Page(s): 69 - 75
    01/01/2021 Authors: LaFemina J; Ahuja V; Alseidi A; Balters M; Brasel K; Clark C; Delman KA; Farley D; Lindeman B; Relles D
  • Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparisonof the Procedure and Outcomes Between the United States and Australia.
    Ann Surg Oncol Volume: 27 Page(s): 5107 - 5118
    12/01/2020 Authors: Carr MJ; Sun J; Kroon HM; Miura JT; Beasley GM; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y
  • Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
    Ann Surg Oncol Volume: 27 Page(s): 983
    12/01/2020 Authors: Farley CR; Perez MC; Soelling SJ; Delman KA; Harit A; Wuthrick EJ; Messina JL; Sondak VK; Zager JS; Lowe MC
  • Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
    Volume: 46 Page(s): 2140 - 2146
    11/01/2020 Authors: Kenyon-Smith TJ; Kroon HM; Miura JT; Teras J; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR
  • Management of Melanoma Patients with Positive Nodes.
    Volume: 54 Page(s): 191 - 204
    09/01/2020 Authors: Lee RM; Delman KA; Lowe MC
  • Implications of COVID-19 on the General Surgery Match.
    Ann Surg Volume: 272 Page(s): e155 - e156
    08/01/2020 Authors: Sell NM; Qadan M; Delman KA; Roggin KK; Spain DA; Phitayakorn R; Lillemoe KD; Mullen JT
  • "What Is Old Is New Again" Commentary on "Ensuring That Step 1 Isn't the Next 'Back in My Day"'.
    Ann Surg Volume: 272 Page(s): 240
    08/01/2020 Authors: Delman KA; Srinivasan JK
  • Minimally invasive inguinal lymphadenectomy.
    J Surg Oncol Volume: 122 Page(s): 96 - 98
    07/01/2020 Authors: Delman KA
  • Development of a surgical oncology training curriculum for accreditation.
    J Surg Oncol Volume: 122 Page(s): 15 - 20
    07/01/2020 Authors: Lee AY; Delman KA; Berman RS
  • The (R)evolution of Melanoma Care.
    Surg Oncol Clin N Am Volume: 29 Page(s): xv - xvi
    07/01/2020 Authors: Delman KA; Lowe MC
  • "What Is Old Is New Again" Commentary on "Ensuring That Step 1 Isn't the Next 'Back in My Day"'.
    Ann Surg
    06/08/2020 Authors: Delman KA; Srinivasan JK
  • Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?
    Ann Surg Oncol Volume: 27 Page(s): 1978 - 1985
    06/01/2020 Authors: Farley CR; Perez MC; Soelling SJ; Delman KA; Harit A; Wuthrick EJ; Messina JL; Sondak VK; Zager JS; Lowe MC
  • Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.
    Volume: 38
    05/20/2020 Authors: Lowe MC; Olson B; Martinez A; Hammons J; Delman KA; Yushak ML; Allor M; Reilly CA; Mallow CL; Evans EE
  • Implications of COVID-19 on the General Surgery Match.
    Ann Surg
    05/20/2020 Authors: Sell NM; Qadan M; Delman KA; Roggin KK; Spain DA; Phitayakorn R; Lillemoe KD; Mullen JT
  • International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Ann Surg Oncol Volume: 27 Page(s): 1420 - 1429
    05/01/2020 Authors: Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR
  • Introducing the "Virtual Tumor Board" series in CA: A Cancer Journal for Clinicians.
    CA Cancer J Clin Volume: 70 Page(s): 77
    03/01/2020 Authors: Delman KA
  • Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia
    Volume: 27 Page(s): S35 - S35
    02/01/2020 Authors: Sun J; Kroon HM; Miura JT; Beasley GM; Farrow NE; Mosca P; Lowe MC; Farley CR; Kim Y; Naqvi SM
  • Recurrence Patterns After Negative Sentinel Lymph Node Biopsy for Melanoma
    Volume: 27 Page(s): S197 - S197
    02/01/2020 Authors: Soelling S; Delman KA; Lowe MC
  • Surgical Considerations and Systemic Therapy of Melanoma.
    Surg Clin North Am Volume: 100 Page(s): 141 - 159
    02/01/2020 Authors: Gamboa AC; Lowe M; Yushak ML; Delman KA
  • Residents Behaving Badly: Pioneering Operations and the Surgical Trainees Who Performed Them.
    J Surg Educ Volume: 77 Page(s): 1392 - 1395
    01/01/2020 Authors: Lovasik BP; Dodson TF; Delman KA; Srinivasan JK
  • Do Internal or External Characteristics More Reliably Predict Burnout in Resident Physicians: A Multi-institutional Study.
    J Surg Educ Volume: 77 Page(s): e86 - e93
    01/01/2020 Authors: Mullins CH; Gleason F; Wood T; Baker SJ; Cortez AR; Lovasik B; Sandhu G; Cooper A; Hildreth AN; Simmons JD
  • Development of a Surgical Evidence Blog at Morbidity and Mortality Conferences: Integrating Clinical Librarians to Enhance Resident Education.
    Volume: 77 Page(s): 1069 - 1075
    01/01/2020 Authors: Lovasik BP; Rutledge H; Lawson E; Maithel SK; Delman KA
  • A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma.
    Ann Surg Oncol Volume: 26 Page(s): 4180 - 4181
    12/01/2019 Authors: Lowe MC; Delman KA
  • The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
    Ann Surg Oncol Volume: 26 Page(s): 4723 - 4729
    12/01/2019 Authors: Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
  • Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?
    Volume: 229 Page(s): 449 - 457
    11/01/2019 Authors: Gamboa AC; Ethun CG; Switchenko JM; Lipscomb J; Poultsides GA; Grignol V; Howard JH; Gamblin TC; Roggin KK; Votanopoulos K
  • Longitudinal Cadaver-Based Simulation Curriculum Creates Sustainable Increases in Resident Confidence and Exposure to Fundamental Techniques: Results of a 5-Year Program Evaluation
    Volume: 229 Page(s): E188 - E188
    10/01/2019 Authors: Lovasik BP; Kim SC; Wang VL; Delman KA; Srinivasan JK
  • The Immune Landscape of Cancer.
    Immunity Volume: 51 Page(s): 411 - 412
    08/20/2019 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Ann Surg Oncol Volume: 26 Page(s): 2486 - 2494
    08/01/2019 Authors: Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH
  • Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
    Lancet Oncol Volume: 20 Page(s): e378 - e389
    07/01/2019 Authors: Amaria RN; Menzies AM; Burton EM; Scolyer RA; Tetzlaff MT; Antdbacka R; Ariyan C; Bassett R; Carter B; Daud A
  • Management of intussusception in patients with melanoma.
    J Surg Oncol Volume: 119 Page(s): 897 - 902
    06/01/2019 Authors: Perez MC; Sun J; Farley C; Han D; Sun AH; Narayan D; Lowe M; Delman KA; Messina JL; Gonzalez RJ
  • Survey of Surgical Oncology Fellowship Graduates 2005-2016: Insight into Initial Practice.
    Ann Surg Oncol Volume: 26 Page(s): 1622 - 1628
    06/01/2019 Authors: Ruff S; Ilyas S; Steinberg SM; Tatalovich Z; McLaughlin SA; D'Angelica M; Raut CP; Delman KA; Hernandez JM; Davis JL
  • Pilot integrated biomarker study of VX15/2503 in combination with ipilimumab and/or nivolumab in patients with resectable metastatic melanoma.
    Volume: 37
    05/20/2019 Authors: Lowe MC; Lesinski GB; Delman KA; Yushak ML; Evans EE; Fisher TL; Kudchadkar RR
  • Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 228 Page(s): 678 - 679
    04/01/2019 Authors: Copeland E; Klimberg VS; Delman K; Bland K; Wood W; Valente S
  • Impact of New Vascular Fellowship Programs on Vascular Surgery Operative Volume of Residents in Associated General Surgery Programs Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 228 Page(s): 532 - 535
    04/01/2019 Authors: Upchurch GR; Langan EM; Chapman WC; Delman KA; Thompson E; Taylor SM; Robinson WP
  • Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System? Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 228 Page(s): 472 - 473
    04/01/2019 Authors: Tyler D; Delman K; Hunt K; Meyers M; Egger M
  • Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.
    J Am Coll Surg Volume: 228 Page(s): 644 - 649
    12/04/2013 Authors: Louie RJ; Perez MC; Jajja MR; Sun J; Collichio F; Delman KA; Lowe M; Sarnaik AA; Zager JS; Ollila DW
  • Can a Structured, Video-Based Cadaver Curriculum Demonstrating Proficiency Enhance Resident Operative Autonomy?
    J Surg Educ Volume: 76 Page(s): e152 - e160
    01/01/2019 Authors: Jajja MR; Lovasik BP; Kim SC; Wang VL; Hinman JM; Delman KA; Srinivasan JK
  • Neoadjuvant therapy of locally/regionally advanced melanoma.
    Ther Adv Med Oncol Volume: 11 Page(s): 1758835919866959
    01/01/2019 Authors: Khunger A; Buchwald ZS; Lowe M; Khan MK; Delman KA; Tarhini AA
  • ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma.
    Ann Surg Oncol Volume: 25 Page(s): 908 - 909
    12/01/2018 Authors: Lowe MC; Farley CR; Delman KA
  • Best Practice for Implementation of the SCORE Portal in General Surgery Residency Training Programs.
    J Surg Educ Volume: 75 Page(s): e11 - e16
    11/01/2018 Authors: Joshi ART; Klingensmith ME; Malangoni MA; Delman KA; Korndorffer JR; Smink DS; Barrett KB; Hickey M
  • Completion Node Dissection After Sentinel Node Biopsy in Melanoma.
    JAMA Surg Volume: 153 Page(s): 1045 - 1046
    11/01/2018 Authors: Delman KA; Wong SL
  • Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?
    J Am Coll Surg Volume: 227 Page(s): 357 - 366.e3
    09/01/2018 Authors: Johnson AC; Ethun CG; Liu Y; Lopez-Aguiar AG; Tran TB; Poultsides G; Grignol V; Howard JH; Bedi M; Gamblin TC
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 174 Page(s): 1034 - 1035
    08/09/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma in situ at the Margin.
    Am Surg Volume: 84 Page(s): 1319 - 1325
    08/01/2018 Authors: Oh G; Farley CR; Lopez-Aguiar AG; Russell MC; Delman KA; Lowe MC
  • Comprehensive Multicenter Graduate Surgical Education Initiative Incorporating Entrustable Professional Activities, Continuous Quality Improvement Cycles, and a Web-Based Platform to Enhance Teaching and Learning.
    J Am Coll Surg Volume: 227 Page(s): 64 - 76
    07/01/2018 Authors: Anderson CI; Basson MD; Ali M; Davis AT; Osmer RL; McLeod MK; Haan PS; Molnar RG; Peshkepija AN; Hardaway JC
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 3698
    06/19/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma (cSCC)
    Volume: 36
    05/20/2018 Authors: Kudchadkar RR; Yushak ML; Lawson DH; Delman KA; Lowe MC; Goings M; McBrien S; Mckellar M; Sieja K; Maynard N
  • The Immune Landscape of Cancer.
    Immunity Volume: 48 Page(s): 812 - 830.e14
    04/17/2018 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
    Cancer Cell Volume: 33 Page(s): 690 - 705.e9
    04/09/2018 Authors: Berger AC; Korkut A; Kanchi RS; Hegde AM; Lenoir W; Liu W; Liu Y; Fan H; Shen H; Ravikumar V
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
    Cancer Cell Volume: 33 Page(s): 721 - 735.e8
    04/09/2018 Authors: Liu Y; Sethi NS; Hinoue T; Schneider BG; Cherniack AD; Sanchez-Vega F; Seoane JA; Farshidfar F; Bowlby R; Islam M
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
    Cancer Cell Volume: 33 Page(s): 676 - 689.e3
    04/09/2018 Authors: Taylor AM; Shih J; Ha G; Gao GF; Zhang X; Berger AC; Schumacher SE; Wang C; Hu H; Liu J
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
    Cancer Cell Volume: 33 Page(s): 706 - 720.e9
    04/09/2018 Authors: Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; Cancer Genome Atlas Research Network; Xie W
  • Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
    Cell Volume: 173 Page(s): 305 - 320.e10
    04/05/2018 Authors: Ding L; Bailey MH; Porta-Pardo E; Thorsson V; Colaprico A; Bertrand D; Gibbs DL; Weerasinghe A; Huang K-L; Tokheim C
  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
    Cell Volume: 173 Page(s): 291 - 304.e6
    04/18/2018 Authors: Hoadley KA; Yau C; Hinoue T; Wolf DM; Lazar AJ; Drill E; Shen R; Taylor AM; Cherniack AD; Thorsson V
  • Pathogenic Germline Variants in 10,389 Adult Cancers.
    Cell Volume: 173 Page(s): 355 - 370.e14
    04/05/2018 Authors: Huang K-L; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 173 Page(s): 371 - 385.e18
    04/05/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
    Cell Volume: 173 Page(s): 400 - 416.e11
    04/05/2018 Authors: Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV
  • Oncogenic Signaling Pathways in The Cancer Genome Atlas.
    Cell Volume: 173 Page(s): 321 - 337.e10
    04/05/2018 Authors: Sanchez-Vega F; Mina M; Armenia J; Chatila WK; Luna A; La KC; Dimitriadoy S; Liu DL; Kantheti HS; Saghafinia S
  • Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
    Cell Volume: 173 Page(s): 338 - 354.e15
    04/05/2018 Authors: Malta TM; Sokolov A; Gentles AJ; Burzykowski T; Poisson L; Weinstein JN; Kamiska B; Huelsken J; Omberg L; Gevaert O
  • A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
    Cell Volume: 173 Page(s): 386 - 399.e12
    04/05/2018 Authors: Chen H; Li C; Peng X; Zhou Z; Weinstein JN; Cancer Genome Atlas Research Network; Liang H
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 313 - 326.e5
    04/03/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
    Cell Rep Volume: 23 Page(s): 297 - 312.e12
    04/03/2018 Authors: Chiu H-S; Somvanshi S; Patel E; Chen T-W; Singh VP; Zorman B; Patil SL; Pan Y; Chatterjee SS; Cancer Genome Atlas Research Network
  • Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Cell Rep Volume: 23 Page(s): 227 - 238.e3
    04/03/2018 Authors: Gao Q; Liang W-W; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao W-W; Reynolds SM; Wyczalkowski MA; Yao L
  • Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
    Cell Rep Volume: 23 Page(s): 255 - 269.e4
    04/03/2018 Authors: Peng X; Chen Z; Farshidfar F; Xu X; Lorenzi PL; Wang Y; Cheng F; Tan L; Mojumdar K; Du D
  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
    Cell Rep Volume: 23 Page(s): 194 - 212.e6
    04/03/2018 Authors: Campbell JD; Yau C; Bowlby R; Liu Y; Brennan K; Fan H; Taylor AM; Wang C; Walter V; Akbani R
  • Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
    Cell Rep Volume: 23 Page(s): 213 - 226.e3
    04/03/2018 Authors: Ge Z; Leighton JS; Wang Y; Peng X; Chen Z; Chen H; Sun Y; Yao F; Li J; Zhang H
  • Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 172 - 180.e3
    04/03/2018 Authors: Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G
  • Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
    Cell Rep Volume: 23 Page(s): 282 - 296.e4
    04/03/2018 Authors: Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; Cancer Genome Atlas Research Network; Buonamici S; Yu L
  • Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
    Cell Rep Volume: 23 Page(s): 270 - 281.e3
    04/03/2018 Authors: Jayasinghe RG; Cao S; Gao Q; Wendl MC; Vo NS; Reynolds SM; Zhao Y; Climente-Gonzlez H; Chai S; Wang F
  • Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 239 - 254.e6
    04/03/2018 Authors: Knijnenburg TA; Wang L; Zimmermann MT; Chambwe N; Gao GF; Cherniack AD; Fan H; Shen H; Way GP; Greene CS
  • Interim Analysis of a Prospective Multi-Institutional Study of Surgery Resident Experience with Flexibility in Surgical Training.
    J Am Coll Surg Volume: 226 Page(s): 425 - 431
    04/01/2018 Authors: Cullinan DR; Wise PE; Delman KA; Potts JR; Awad MM; Eberlein TJ; Klingensmith ME
  • Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
    Cell Syst Volume: 6 Page(s): 271 - 281.e7
    03/28/2018 Authors: Ellrott K; Bailey MH; Saksena G; Covington KR; Kandoth C; Stewart C; Hess J; Ma S; Chiotti KE; McLellan M
  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
    Cell Syst Volume: 6 Page(s): 282 - 300.e2
    03/28/2018 Authors: Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y
  • Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    BMC Cancer Volume: 18 Page(s): 130
    02/05/2018 Authors: Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR
  • Reexamining the Role of Pelvic Lymphadenectomy for Melanoma in the Era of Effective Systemic Therapy: A Multi-Institutional Experience
    Volume: 25 Page(s): S177 - S177
    02/01/2018 Authors: Farley CR; Perez M; Zager JS; Lee A; Berman R; Hyngstrom J; Delman K; Lowe M
  • Management of Intussusception Secondary to Metastatic Melanoma
    Volume: 25 Page(s): S178 - S178
    02/01/2018 Authors: Perez M; Farley CR; Han D; Sun A; Narayan D; Lowe M; Delman K; Messina JL; Gonzalez R; Sondak VK
  • Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
    Ann Surg Oncol Volume: 25 Page(s): 465 - 470
    02/01/2018 Authors: Postlewait LM; Farley CR; Seamens AM; Le N; Rizzo M; Russell MC; Lowe MC; Delman KA
  • Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    J Clin Oncol Volume: 36 Page(s): 399 - 413
    02/01/2018 Authors: Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA
  • Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Ann Surg Oncol Volume: 25 Page(s): 356 - 377
    02/01/2018 Authors: Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA
  • Increase in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma.
    Oncoimmunology Volume: 7 Page(s): e1442168
    01/01/2018 Authors: Patel KR; Martinez A; Stahl JM; Logan SJ; Perricone AJ; Ferris MJ; Buchwald ZS; Chowdhary M; Delman KA; Monson DK
  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
    Cell Volume: 171 Page(s): 950 - 965.e28
    11/02/2017 Authors: Cancer Genome Atlas Research Network. Electronic address: elizabeth.demicco@sinaihealthsystem.ca; Cancer Genome Atlas Research Network
  • The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.
    Ann Surg Oncol Volume: 24 Page(s): 3574 - 3586
    11/01/2017 Authors: Broecker JS; Ethun CG; Monson DK; Lopez-Aguiar AG; Le N; McInnis M; Godette K; Reimer NB; Oskouei SV; Delman KA
  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    CA Cancer J Clin Volume: 67 Page(s): 472 - 492
    11/01/2017 Authors: Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA
  • A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol Volume: 24 Page(s): 3237 - 3244
    10/01/2017 Authors: Postlewait LM; Farley CR; Diller ML; Martin B; Hart Squires M; Russell MC; Rizzo M; Ogan K; Master V; Delman K
  • Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 224 Page(s): 659 - 661
    04/01/2017 Authors: Zager J; Delman K; Polk H; Klauber-Demore N; Mcmasters K; Meyers M
  • Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 224 Page(s): 642 - 644
    04/01/2017 Authors: Delman K; Scoggins C; Gonzalez R
  • Do female surgeons learn or teach differently?
    Am J Surg Volume: 213 Page(s): 282 - 287
    02/01/2017 Authors: Nebeker CA; Basson MD; Haan PS; Davis AT; Ali M; Gupta RN; Osmer RL; Hardaway JC; Peshkepija AN; McLeod MK
  • A taxonomy of perioperative surgical learning: Trending resident skill acquisition.
    Am J Surg Volume: 213 Page(s): 260 - 267
    02/01/2017 Authors: Hardaway JC; Basson MD; Ali M; Davis AT; Haan PS; Gupta RN; Peshkepija AN; Nebeker CA; McLeod MK; Osmer RL
  • Revisiting the Strait of Messina: The Balance Between Optimal Oncologic Outcomes and Complications From Surgery.
    Ann Surg Oncol Volume: 24 Page(s): 302 - 304
    02/01/2017 Authors: Delman KA; Lowe MC
  • Melanoma Risk Prediction in Elderly Melanoma Patients with a 31-Gene Expression Profile Test
    Volume: 24 Page(s): S143 - S143
    02/01/2017 Authors: Zager JS; Messina JL; Lawson DH; Wayne JD; Gerami P; Gastman B; Delman K
  • Outcomes Following Failed Sentinel Lymph Node Biopsy Due to Non-localizing Lymphoscintigraphy
    Volume: 24 Page(s): S145 - S145
    02/01/2017 Authors: Farley C; Arciero C; Rizzo M; Russell M; Delman K; Lowe M
  • The Prognostic Value of Pathologic Complete Response following Neoadjuvant Therapy in Soft Tissue Sarcoma
    Volume: 24 Page(s): S31 - S31
    02/01/2017 Authors: Ethun CG; Lopez-Aguiar AG; Monson DK; McInnis MR; Le N; Reimer NB; Oskouei S; Delman K; Staley CA; Maithel SK
  • The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas
    Volume: 24 Page(s): S165 - S166
    02/01/2017 Authors: Broecker JS; Ethun CG; Monson DK; Lopez-Aguiar A; Le N; McInnis MR; Reimer NB; Oskouei S; Delman K; Staley CA
  • Perspective of a Program Director
    Page(s): 35 - 41
    01/01/2017 Authors: Srinivasan J; Delman K
  • The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.
    Melanoma Res Volume: 26 Page(s): 595 - 603
    12/01/2016 Authors: Danish HH; Patel KR; Switchenko JM; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
  • Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol Volume: 23 Page(s): 4169 - 4177
    12/01/2016 Authors: Andtbacka RHI; Ross M; Puzanov I; Milhem M; Collichio F; Delman KA; Amatruda T; Zager JS; Cranmer L; Hsueh E
  • Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training.
    Ann Surg Oncol Volume: 23 Page(s): 4049 - 4057
    11/01/2016 Authors: Lovasik BP; Sharma I; Russell MC; Carlson GW; Delman KA; Rizzo M
  • Despite Guidelines, Preoperative Administration of Subcutaneous Heparin for Venous Thromboembolism Prophylaxis Is Severely Underutilized
    Volume: 223 Page(s): S140 - S140
    10/01/2016 Authors: Razavi SA; Styblo TM; Sarmiento JM; Kooby DA; Sullivan PS; Maithel S; Shaffer VL; Staley CA; Delman KA
  • The Influence of Postoperative Lymph Node Radiation Therapy on Overall Survival of Patients With Stage III Melanoma: A National Cancer Data Base Analysis
    Volume: 96 Page(s): S157 - S158
    10/01/2016 Authors: Danish H; Patel K; Switchenko J; Gillespie W; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
  • The Influence of Postoperative Lymph Node Radiation Therapy on Overall Survival of Patients With Stage III Melanoma: A National Cancer Data Base Analysis
    Volume: 96 Page(s): S157 - S158
    10/01/2016 Authors: Danish H; Patel K; Switchenko J; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
  • The Influence of Postoperative Lymph Node Radiation Therapy on Overall Survival of Patients With Stage III Melanoma: A National Cancer Data Base Analysis.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S157 - S158
    10/01/2016 Authors: Danish H; Patel K; Switchenko J; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
  • Complete response to high-dose IL-2 and enhanced IFN+Th17: TREG ratio in a melanoma patient.
    Melanoma Res Volume: 26 Page(s): 535 - 539
    10/01/2016 Authors: Diller ML; Kudchadkar RR; Delman KA; Lawson DH; Ford ML
  • Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    J Am Coll Surg Volume: 222 Page(s): 357 - 363
    04/01/2016 Authors: Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RCG; Philips P; Scoggins CR
  • Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 222 Page(s): 709 - 711
    04/01/2016 Authors: Tyler D; Delman K; McMasters K; Timberlake G; Dossett L
  • Surgical Training and the Early Specialization Program: Analysis of a National Program Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 222 Page(s): 416 - 418
    04/01/2016 Authors: Britt LD; Fleshman JW; Polk H; Meyer A; Sheahan M; Delman K; Klingensmith M
  • The importance of surgical margins in melanoma.
    J Surg Oncol Volume: 113 Page(s): 339 - 345
    03/01/2016 Authors: Ethun CG; Delman KA
  • Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
    J Mol Diagn Volume: 18 Page(s): 299 - 315
    03/01/2016 Authors: Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS
  • Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.
    Melanoma Res Volume: 26 Page(s): 35 - 41
    02/01/2016 Authors: Oliver DE; Patel KR; Switchenko J; Parker D; Lawson DH; Delman KA; Kudchadkar RR; Khan MK
  • Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients.
    J Immunother Volume: 39 Page(s): 355 - 366
    01/01/2016 Authors: Diller ML; Kudchadkar RR; Delman KA; Lawson DH; Ford ML
  • Cadaver-Based Simulation Increases Resident Confidence, Initial Exposure to Fundamental Techniques, and May Augment Operative Autonomy.
    J Surg Educ Volume: 73 Page(s): e33 - e41
    01/01/2016 Authors: Kim SC; Fisher JG; Delman KA; Hinman JM; Srinivasan JK
  • Balancing Inflammation: The Link between Th17 and Regulatory T Cells.
    Mediators Inflamm Volume: 2016 Page(s): 6309219
    01/01/2016 Authors: Diller ML; Kudchadkar RR; Delman KA; Lawson DH; Ford ML
  • Roles of Adjuvant and Salvage Radiation Therapy for Desmoplastic Melanoma
    Volume: 93 Page(s): E629 - E629
    11/01/2015 Authors: Oliver DE; Patel K; Switchenko J; Parker DC; Lawson DH; Delman KA; Kudchadkar RR; Khan MK
  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
    J Clin Oncol Volume: 33 Page(s): 2780 - 2788
    09/01/2015 Authors: Andtbacka RHI; Kaufman HL; Collichio F; Amatruda T; Senzer N; Chesney J; Delman KA; Spitler LE; Puzanov I; Agarwala SS
  • Tanning beds: A call to action for further educational and legislative efforts.
    J Surg Oncol Volume: 112 Page(s): 183 - 187
    08/01/2015 Authors: Farley C; Alimi Y; Espinosa LR; Perez S; Knechtle W; Hestley A; Carlson GW; Russell MC; Delman KA; Rizzo M
  • Transition to surgical residency: a multi-institutional study of perceived intern preparedness and the effect of a formal residency preparatory course in the fourth year of medical school.
    Acad Med Volume: 90 Page(s): 1116 - 1124
    08/01/2015 Authors: Minter RM; Amos KD; Bentz ML; Blair PG; Brandt C; D'Cunha J; Davis E; Delman KA; Deutsch ES; Divino C
  • High dose IL-2 (HDIL-2) results in increased PD-1 expression on CD45RA-CCR7-CD8+and CD45RA-CCR7-CD4+T cells in melanoma patients
    Volume: 75
    08/01/2015 Authors: Diller ML; Maio S; Eysmans GE; Lawson D; Delman KA; Kudchadkar RR; Ford ML
  • Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
    Volume: 22 Page(s): 2295 - 2301
    07/01/2015 Authors: Squires MH; Volkan Adsay N; Schuster DM; Russell MC; Cardona K; Delman KA; Winer JH; Altinel D; Sarmiento JM; El-Rayes B
  • Genomic Classification of Cutaneous Melanoma.
    Cell Volume: 161 Page(s): 1681 - 1696
    06/18/2015 Authors: Cancer Genome Atlas Network
  • Analysis of CTLA4 expression on T regulatory cells in patients with advanced stage melanoma in the setting of high dose IL-2 (HDIL-2)
    Volume: 33
    05/20/2015 Authors: Diller ML; Eysmans CE; Lawson DH; Delman KA; Kudchadkar RR; Ford M
  • Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC)
    Volume: 33
    05/20/2015 Authors: Kaufman H; Amatruda T; Nemunaitis JJ; Chesney JA; Delman KA; Spitler LE; Collichio FA; Ross MI; Zhang Y; Shilkrut M
  • Extramammary Paget's disease in males: survival outcomes in 495 patients.
    Ann Surg Oncol Volume: 22 Page(s): 1625 - 1630
    05/01/2015 Authors: Herrel LA; Weiss AD; Goodman M; Johnson TV; Osunkoya AO; Delman KA; Master VA
  • Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
    J Am Acad Dermatol Volume: 72 Page(s): 780 - 5.e3
    05/01/2015 Authors: Gerami P; Cook RW; Russell MC; Wilkinson J; Amaria RN; Gonzalez R; Lyle S; Jackson GL; Greisinger AJ; Johnson CE
  • Melanoma risk prediction of a validated genetic signature compared to the AJCC online predictor
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Volume: 72 Page(s): AB172 - AB172
    05/01/2015 Authors: Ferris L; Cook R; Wilkinson J; Lassen N; Johnson C; Oelschlager K; Stone J; Maetzold D; Russell M; Delman K
  • The emerging role of radiotherapy for desmoplastic melanoma and implications for future research.
    Melanoma Res Volume: 25 Page(s): 95 - 102
    04/01/2015 Authors: Oliver DE; Patel KR; Parker D; Delman KA; Lawson DH; Kudchadkar RR; Khan MK
  • Lymph node dissection for stage III melanoma.
    Surg Oncol Clin N Am Volume: 24 Page(s): 261 - 277
    04/01/2015 Authors: Diller ML; Martin BM; Delman KA
  • Scalp Melanoma: Role for Enhanced Detection through Professional Training
    Volume: 22 Page(s): S116 - S117
    02/01/2015 Authors: Russell M; Sharma I; Lovasik B; Delman K; Rizzo M
  • Gene Expression Profile (GEP) Enhances Prognostic Value of Sentinel Lymph Node Biopsy (SLNB) in a Cohort of Patients with Head and Neck Melanoma
    Volume: 22 Page(s): S121 - S121
    02/01/2015 Authors: Diller M; Wilkinson J; Jackson G; Greisinger A; Amaria R; Gonzalez R; Stone J; Ferris L; Gerami P; Wayne J
  • Lower Risk of Visceral/Bone Metastasis (VM) in Patients with Stage IIIB/C/IVM1a Melanoma Treated with Talimogene Laherparepvec (T-VEC) versus GM-CSF in OPTiM (NCT00769704)
    Volume: 22 Page(s): S23 - S23
    02/01/2015 Authors: Andtbacka RH; Kaufman HL; Frances CA; Delman K; Zager JS; Hsueh E; Chen L; Shilkrut M; Ross M
  • Primary Overall Survival (OS) from OPTiM, a Randomized Phase 3 Trial of Talimogene Laherparepvec (T-VEC) versus Subcutaneous (SC) Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for the Treatment of Unresected Stage IIIB/C/IV Melanoma
    Volume: 22 Page(s): S126 - S126
    02/01/2015 Authors: Kaufman H; Andtbacka RH; Collichio F; Amatruda T; Senzer N; Chesney J; Delman K; Spitler LE; Puzanov I; Ye Y
  • Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
    Clin Cancer Res Volume: 21 Page(s): 175 - 183
    01/01/2015 Authors: Gerami P; Cook RW; Wilkinson J; Russell MC; Dhillon N; Amaria RN; Gonzalez R; Lyle S; Johnson CE; Oelschlager KM
  • Comparative effectiveness in melanoma.
    Cancer Treat Res Volume: 164 Page(s): 31 - 49
    01/01/2015 Authors: Russel MC; Delman KA
  • Emory global surgery program: learning to serve the underserved well.
    J Surg Educ Volume: 72 Page(s): e46 - e51
    01/01/2015 Authors: Love TP; Martin BM; Tubasiime R; Srinivasan J; Pollock JD; Delman KA
  • Early Results from the Flexibility in Surgical Training Research Consortium: Resident and Program Director Attitudes Toward Flexible Rotations in Senior Residency.
    J Surg Educ Volume: 72 Page(s): e151 - e157
    01/01/2015 Authors: Klingensmith ME; Awad M; Delman KA; Deveney K; Fahey TJ; Lees JS; Lipsett P; Mullen JT; Smink DS; Wayne J
  • Foreword.
    Curr Probl Cancer Volume: 39 Page(s): 273
    01/01/2015 Authors: Delman KA
  • Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Am J Clin Oncol Volume: 37 Page(s): 580 - 584
    12/01/2014 Authors: Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW
  • Foreword.
    BJOG Volume: 121 Suppl 4 Page(s): 1
    09/01/2014 Authors: Brown S
  • Evaluation of the Safety and Quality of Videoscopic Inguinal Lymphadenectomy: Mitigation of Patient Comorbidities by a Minimally Invasive Technique
    Volume: 219 Page(s): S124 - S124
    09/01/2014 Authors: Squires MH; Master VA; Kooby DA; Russell MC; Rizzo M; Ogan K; Martin BM; Longwell AB; Carlson GW; Delman KA
  • Primary overall survival (OS) from OPTiM, a randomized phase Ill trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.
    Volume: 32
    05/20/2014 Authors: Kaufman HL; Andtbacka RHI; Collichio FA; Amatruda T; Senzer NN; Chesney J; Delman KA; Spitler LE; Puzanov I; Ye Y
  • Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).
    Volume: 32
    05/20/2014 Authors: Lawson DH; Russell MC; Wilkinson J; Jackson GL; Greisinger A; Amaria RN; Gonzalez R; Lyle S; Johnson C; Oelschlager KM
  • Patterns of durable response with intralesional talimogene laherparepvec (T-VEC): Results from a phase Ill trial in patients with stage IIIb-IV melanoma.
    Volume: 32
    05/20/2014 Authors: Ross MI; Andtbacka RHI; Puzanov I; Milhem MM; Collichio FA; Delman KA; Noyes RD; Zager JS; Cranmer LD; Spitler LE
  • Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma.
    J Am Coll Surg Volume: 218 Page(s): 620 - 626
    04/01/2014 Authors: Martin BM; Etra JW; Russell MC; Rizzo M; Kooby DA; Staley CA; Master VA; Delman KA
  • Perceptions of Graduating General Surgery Chief Residents: Are They Confident in Their Training? Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 218 Page(s): 703 - 706
    04/01/2014 Authors: Postier RG; Ashley SW; Britt LD; Walker P; Delman K; Brunt M; Malangoni M; Gaines B; Friedell ML
  • Can Laparoscopic Cholecystectomy Be Performed with a Positive Margin at Medicaid Reimbursement Rates? Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 218 Page(s): 551 - 553
    04/01/2014 Authors: Britt LD; Edwards M; Lynn R; Delman K; Frazee RC
  • Discussion.
    J Am Coll Surg Volume: 218 Page(s): 692 - 694
    04/01/2014
  • Efficacy of Repeat Sentinel Lymph Node Biopsy in Patients Who Develop Recurrent Melanoma Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 218 Page(s): 692 - 694
    04/01/2014 Authors: Slingluff C; Delman K; McMasters K; Beasley G
  • Oncologic Outcomes of Patients Undergoing Videoscopic Inguinal Lymphadenectomy for Metastatic Melanoma Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 218 Page(s): 626 - 627
    04/01/2014 Authors: Tyler D; Taylor SM; Myers M; Delman K
  • Discussion.
    J Am Coll Surg Volume: 218 Page(s): 626 - 627
    04/01/2014
  • Discussion.
    J Am Coll Surg Volume: 218 Page(s): 703 - 706
    04/01/2014
  • The risk of lymph node involvement in malignant cutaneous adnexal tumors.
    Am Surg Volume: 80 Page(s): 270 - 274
    03/01/2014 Authors: Barnes M; Hestley A; Murray DR; Carlson GW; Parker D; Delman KA
  • Responses of Injected and Uninjected Lesions to Intralesional Talimogene Laherparepvec (T-VEC) in the OPTiM Study and the Contribution of Surgery to Response
    Volume: 21 Page(s): S23 - S23
    02/01/2014 Authors: Andtbacka RH; Ross MI; Delman K; Noyes D; Zager JS; Hsueh E; Ollila DW; Amatruda T; Chen L; VanderWalde A
  • Tanning Beds: How Harmful are they in Young Patients with Melanoma?
    Volume: 21 Page(s): S113 - S113
    02/01/2014 Authors: Farley C; Alimi Y; Perez S; Knechtle W; Hestley A; Carlson GW; Russell MC; Delman K; Rizzo M
  • Current Problems in Cancer. Hereditary cancer: practical information for the oncology community. Foreword.
    Curr Probl Cancer Volume: 38 Page(s): 208
    01/01/2014 Authors: Delman KA
  • Pediatric melanoma: analysis of an international registry.
    Cancer Volume: 119 Page(s): 4012 - 4019
    11/15/2013 Authors: Averbook BJ; Lee SJ; Delman KA; Gow KW; Zager JS; Sondak VK; Messina JL; Sabel MS; Pittelkow MR; Ecker PM
  • The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist?
    J Am Coll Surg Volume: 217 Page(s): 881 - 888
    11/01/2013 Authors: Fisher SB; Baxter KJ; Staley CA; Fisher KE; Monson DK; Murray DR; Oskouei SV; Weiss SW; Kooby DA; Maithel SK
  • OPTIM: A RANDOMISED PHASE 3 TRIAL OF TALIMOGENE LAHERPAREPVEC (T-VEC) VS SUBCUTANEOUS (SC) GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR THE TREATMENT OF UNRESECTED STAGE IIIB/C AND IV MELANOMA
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Volume: 9 Page(s): 74 - 75
    11/01/2013 Authors: Andtbacka RHI; Collichio F; Amatruda T; Senzer N; Chesney J; Delman KA; Spitler LE; Puzanov I; Doleman S; Ye Y
  • Minimizing morbidity in melanoma surgery.
    Oncology (Williston Park) Volume: 27 Page(s): 1016 - 1020
    10/01/2013 Authors: Martin BM; Master VA; Delman KA
  • Current treatment of locoregional recurrence of melanoma.
    Curr Oncol Rep Volume: 15 Page(s): 465 - 472
    10/01/2013 Authors: Squires MH; Delman KA
  • Videoscopic inguinal lymphadenectomy for metastatic melanoma.
    Cancer Control Volume: 20 Page(s): 255 - 260
    10/01/2013 Authors: Martin BM; Master VA; Delman KA
  • Secondary endpoints from OPTiM: A multicenter, randomized phase 3 trial of talimogene laherparepvec vs GM-CSF for the treatment of unresected stage IIIB/C and IV melanoma
    Volume: 49 Page(s): S865 - S866
    09/01/2013 Authors: Kaufman H; Andtbacka RHI; Harrington K; Collichio F; Amatruda T; Senzer N; Chesney J; Delman KA; VanderWalde A; Coffin R
  • OPTiM: A Multicenter, Randomized Phase 3 Trial of Talimogene Laherparepvec versus Subcutaneous GM-CSF for the Treatment of Unresected Stage IIIB/C and IV Melanoma
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT Volume: 11 Page(s): 8 - 8
    07/01/2013 Authors: Andtbacka RH; Collichio F; Amatruda T; Senzer N; Chesney J; Delman K; Spitler L; Puzanov I; Doleman S; Ye Y
  • Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients.
    Am Surg Volume: 79 Page(s): 657 - 665
    07/01/2013 Authors: Fisher SB; Kim SC; Kooby DA; Cardona K; Russell MC; Delman KA; Staley CA; Maithel SK
  • OPTiM: A randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.
    J Clin Oncol Volume: 31 Page(s): LBA9008
    06/20/2013 Authors: Collichio FA; Amatruda T; Senzer NN; Chesney J; Delman KA; Spitler LE; Puzanov I; Doleman S; Ye Y; Vanderwalde AM
  • Scrotal cancer survival is influenced by histology: a SEER study.
    World J Urol Volume: 31 Page(s): 585 - 590
    06/01/2013 Authors: Johnson TV; Hsiao W; Delman KA; Canter DJ; Master VA
  • Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma.
    Head Neck Volume: 35 Page(s): 667 - 671
    05/01/2013 Authors: McDonald K; Page AJ; Jordan SW; Chu C; Hestley A; Delman KA; Murray DR; Carlson GW
  • Malignant Cutaneous Adnexal Tumors Do not Require Routine Sentinel Lymph Node Biopsy
    Volume: 20 Page(s): S110 - S110
    02/01/2013 Authors: Barnes MA; Hestley A; Murray DR; Rizzo M; Carlson GW; Parker DC; Delman KA
  • 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival?
    Ann Surg Oncol Volume: 20 Page(s): 346 - 351
    01/01/2013 Authors: Hudson LE; Maithel SK; Carlson GW; Rizzo M; Murray DR; Hestley AC; Delman KA
  • Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.
    J Urol Volume: 188 Page(s): 1176 - 1180
    10/01/2012 Authors: Master VA; Jafri SMA; Moses KA; Ogan K; Kooby DA; Delman KA
  • CD45/CD8 Myeloid Histioid Antigen and Plasma Cell Antibody Immune Response in a Case of Malignant Melanoma.
    N Am J Med Sci Volume: 4 Page(s): 507 - 509
    10/01/2012 Authors: Abreu-Velez AM; Howard MS; Pereyo NY; Delman KA; Mihm MC; Rizzo M
  • Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma.
    Can J Urol Volume: 19 Page(s): 6395 - 6400
    08/01/2012 Authors: Canter DJ; Dobbs RW; Jafri SMA; Herrel LA; Ogan K; Delman KA; Master VA
  • Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach.
    Can J Urol Volume: 19 Page(s): 6306 - 6309
    06/01/2012 Authors: Herrel LA; Butterworth RM; Jafri SM; Ying C; Delman KA; Kooby DA; Ogan KE; Canter DJ; Master VA
  • Pediatric melanomas and the atypical spitzoid melanocytic neoplasms.
    Am J Surg Volume: 203 Page(s): 761 - 767
    06/01/2012 Authors: Hill SJ; Delman KA
  • Gene expression profile signature (DecisionDx-Melanoma) to predict visceral metastatic risk in patients with stage I and stage II cutaneous melanoma.
    Volume: 30
    05/20/2012 Authors: Dhillon N; Rogers AR; Delman KA; Maetzold D; Oelschlager KM; Lyle S; Jackson GL; Greisinger A; Parker D; Cook RW
  • A Novel and Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model Discussion
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 214 Page(s): 617 - 619
    04/01/2012 Authors: Greene F; Murray D; Delman K; Reiling R; Callender G
  • MINIMALLY INVASIVE INGUINAL LYMPHADENECTOMY VIA ENDOSCOPIC GROIN DISSECTION: COMPREHENSIVE ASSESSMENT OF IMMEDIATE AND LONG-TERM COMPLICATIONS
    Volume: 187 Page(s): E376 - E376
    04/01/2012 Authors: Master VA; Jafri SMA; Herrel L; Ogan K; Kooby DA; Delman KA
  • Risk and Location of Additional Cervical Lymph Node Involvement in Melanoma Patients with a Positive Cervical Sentinel Lymph Node Biopsy
    Volume: 19 Page(s): S128 - S128
    02/01/2012 Authors: Hyngstrom JR; Gardner JM; Delman KA; Yang A; Schacherer CW; Cormier JN; Gershenwald JE; Mansfield PF; Lucci A; Royal R
  • 1 vs 2 cm Surgical Excision for 1-2 mm Melanomas: Does it Matter?
    Volume: 19 Page(s): S24 - S24
    02/01/2012 Authors: Hudson L; Carlson GW; Hestley A; Murray D; Rizzo M; Maithel SK; Delman KA
  • Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma.
    Int J Surg Oncol Volume: 2012 Page(s): 456987
    01/01/2012 Authors: Page AJ; Li A; Hestley A; Murray D; Carlson GW; Delman KA
  • Inguinopelvic lymphadenectomy following positive inguinal sentinel lymph node biopsy in melanoma: true frequency of synchronous pelvic metastases.
    Ann Surg Oncol Volume: 18 Page(s): 3309 - 3315
    11/01/2011 Authors: Chu CK; Delman KA; Carlson GW; Hestley AC; Murray DR
  • Gastrointestinal Stromal Tumors Foreword
    CURRENT PROBLEMS IN CANCER Volume: 35 Page(s): 232 - 232
    09/01/2011 Authors: Delman KA
  • The impact of shave biopsy on the management of patients with thin melanomas.
    Am Surg Volume: 77 Page(s): 1050 - 1053
    08/01/2011 Authors: Lowe M; Hill N; Page A; Chen S; Delman KA
  • Melanoma Foreword
    CURRENT PROBLEMS IN CANCER Volume: 35 Page(s): 137 - 137
    07/01/2011 Authors: Delman KA
  • Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.
    Arch Surg Volume: 146 Page(s): 870 - 875
    07/01/2011 Authors: Turaga KK; Beasley GM; Kane JM; Delman KA; Grobmyer SR; Gonzalez RJ; Letson GD; Cheong D; Tyler DS; Zager JS
  • Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.
    Ann Surg Oncol Volume: 18 Page(s): 1327 - 1334
    05/01/2011 Authors: Kneuertz PJ; Patel SH; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
  • EXTRAMAMMARY PAGET'S DISEASE IN MALES: A SEER STUDY IN SURVIVAL
    Volume: 185 Page(s): E240 - E240
    04/01/2011 Authors: Herrel LA; Johnson TV; Master VA; Delman KA
  • Initial experience with videoscopic inguinal lymphadenectomy.
    Ann Surg Oncol Volume: 18 Page(s): 977 - 982
    04/01/2011 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Master V
  • Extramammary Paget's disease of the penis and anogenital area: SEER analysis
    JOURNAL OF CLINICAL ONCOLOGY Volume: 29
    03/01/2011 Authors: Master VA; Herrel L; Johnson TV; Delman KA
  • Extramammary Paget's disease of the penis and anogenital area: SEER analysis.
    J Clin Oncol Volume: 29 Page(s): 220
    03/01/2011 Authors: Master VA; Herrel L; Johnson TV; Delman KA
  • Nutrition and its relationship to cancer. Foreword.
    Curr Probl Cancer Volume: 35 Page(s): 56 - 57
    01/01/2011 Authors: Delman KA
  • Foreword. Gastrointestinal stromal tumors.
    Curr Probl Cancer Volume: 35 Page(s): 232
    01/01/2011 Authors: Delman KA
  • Ipilimumab for advanced melanoma: let's not throw caution to the winds.
    Oncology (Williston Park) Volume: 24 Page(s): 1296 - 1299
    12/01/2010 Authors: Lowe M; Delman KA
  • Routine biopsy of Cloquet's node is of limited value in sentinel node positive melanoma patients.
    J Surg Oncol Volume: 102 Page(s): 315 - 320
    09/15/2010 Authors: Chu CK; Zager JS; Marzban SS; Gimbel MI; Murray DR; Hestley AC; Messina JL; Sondak VK; Carlson GW; Delman KA
  • Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms.
    Ann Surg Oncol Volume: 17 Page(s): 2471 - 2475
    09/01/2010 Authors: Ghazi B; Carlson GW; Murray DR; Gow KW; Page A; Durham M; Kooby DA; Parker D; Rapkin L; Lawson DH
  • Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program.
    Cancer Volume: 116 Page(s): 2960 - 2966
    06/15/2010 Authors: Johnson TV; Hsiao W; Delman KA; Jani AB; Brawley OW; Master VA
  • The role of radio-surgery in patients with metastatic melanoma to the brain
    Volume: 28
    05/20/2010 Authors: Lowe MC; Cavitt A; Shelton J; Crocker IR; Pan L; Lawson DH; Carlson GW; Delman KA; Rizzo M
  • Deep margin involvement after shave biopsy-for melanoma and requirement for sentinel lymph node biopsy (SLAB)
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Page A; Lowe MC; Hill N; Murray DR; Carlson GW; Bonaccorsi P; Chen S; Delman KA
  • Rate of positive Sentinel Lymph Node Biopsy (SLNB) in shave vs. punch biopsies of thin (< 1mm) melanomas
    Volume: 130 Page(s): S67 - S67
    04/01/2010 Authors: Hill N; Page A; Bonaccorsi P; Delman K; Veledar E; Chen SC
  • Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.
    Ann Surg Oncol Volume: 17 Page(s): 731 - 737
    03/01/2010 Authors: Delman KA; Kooby DA; Ogan K; Hsiao W; Master V
  • Synchronous pelvic disease in unselected sentinel-node positive melanoma patients treated with routine complete inguinopelvic lymphadenectomy
    Volume: 17 Page(s): S110 - S111
    02/01/2010 Authors: Chu CK; Delman KA; Hestley A; Carlson GW; Murray DE
  • Allogeneic red blood cell transfusion following pancreaticoduodenectomy for ductal adenocarcinoma is associated with earlier recurrence and reduced survival
    Volume: 17 Page(s): S81 - S82
    02/01/2010 Authors: Kneuertz PJ; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
  • Limb Preservation with Isolated Limb Infusion for Unresectable Non-melanoma Cutaneous and Soft Tissue Malignancies
    Volume: 17 Page(s): S32 - S32
    02/01/2010 Authors: Turaga KK; Beasley GM; Gonzalez RJ; Delman KA; Letson GD; Cheong D; Tyler DS; Zager JS
  • Growing Experience with Videoscopic Inguinal Lymphadenectomy (VIL): Moving Towards Better Outcomes
    Volume: 17 Page(s): S15 - S15
    02/01/2010 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Maithel SK; Master V
  • Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
    J Vasc Interv Radiol Volume: 21 Page(s): 224 - 230
    02/01/2010 Authors: Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
  • Merkel Cell Carcinoma Foreword
    CURRENT PROBLEMS IN CANCER Volume: 34 Page(s): 13 - 13
    01/01/2010 Authors: Delman KA
  • Management of regional lymph node basins in melanoma.
    Ochsner J Volume: 10 Page(s): 99 - 107
    01/01/2010 Authors: Love TP; Delman KA
  • Foreword. Merkel cell carcinoma.
    Curr Probl Cancer Volume: 34 Page(s): 13
    01/01/2010 Authors: Delman KA
  • Commentary on pharmacotherapy of regional melanoma therapy.
    Expert Opin Pharmacother Volume: 11 Page(s): 1 - 3
    01/01/2010 Authors: Zager JS; Delman KA
  • Enhancing resident interest in a state surgical meeting.
    J Surg Educ Volume: 67 Page(s): 190 - 193
    01/01/2010 Authors: Fuhrman GM; MacLeod J; Ehleben C; Delman K
  • Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique.
    Eur Urol Volume: 56 Page(s): 821 - 828
    11/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • LEG ENDOSCOPIC GROIN LYMPHADENECTOMY FOR GENITOURINARY CANCER (LEG PROCEDURE)
    JOURNAL OF ENDOUROLOGY Volume: 23 Page(s): A53 - A53
    10/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.
    Ann Surg Oncol Volume: 16 Page(s): 2570 - 2578
    09/01/2009 Authors: Santillan AA; Delman KA; Beasley GM; Mosca PJ; Hochwald SN; Grobmyer SR; Andtbacka RH; Noyes RD; Kane JM; Ross MI
  • First analysis of an international pediatric melanoma and atypical melanocytic neoplasm database.
    J Clin Oncol Volume: 27 Page(s): 9013
    05/20/2009 Authors: Averbook BJ; Jukic D; Rao JS; Panneerselvam A; Delman K; Zager JS; Sabel M; Pittelkow MR; Swetter S; Kirkwood JM
  • First analysis of an international pediatric melanoma and atypical melanocytic neoplasm database
    Volume: 27
    05/20/2009 Authors: Averbook BJ; Jukic D; Rao JS; Panneerselvam A; Delman K; Zager JS; Sabel M; Pittelkow MR; Swetter S
  • A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
    J Am Coll Surg Volume: 208 Page(s): 706 - 715
    05/01/2009 Authors: Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA
  • Chemoembolization Combined with Radiofrequency Ablation for Hepato cellular Carcinoma; Survival Benefits and Tumor Treatment Response
    Volume: 192
    05/01/2009 Authors: Dhanasekaran R; Khanna V; Kooby D; Delman K; Staley C; Kauh J; Carew J; Kim H
  • Peritoneal Surface Malignancy Foreword
    CURRENT PROBLEMS IN CANCER Volume: 33 Page(s): 123 - 124
    05/01/2009 Authors: Delman KA
  • ENDOSCOPIC MODIFIED INGUINAL LYMPHADENECTOMY: LEG ENDOSCOPIC GROIN (LEG) PROCEDURE
    Volume: 181 Page(s): 605 - 606
    04/01/2009 Authors: Hsiao W; Herrel L; Delman KA; Ogan K; Master VA
  • Melanomas without an Epidermal Component: Metastatic or Unique Primary Lesions?
    Volume: 16 Page(s): 95 - 96
    02/01/2009 Authors: Singh KA; Carlson GW; Murray D; Hestley A; Rizzo M; Kooby D; Staley C; Lawson D; Delman K
  • Age Dependent Variations in Recurrence After Sentinel Node Biopsy in Melanoma
    Volume: 16 Page(s): 97 - 97
    02/01/2009 Authors: Page AJ; Carlson GW; Murray D; Goodman M; Li A; Hestley A; Rizzo M; Delman KA
  • Aggressive surgical therapy for metastatic disease is appropriate in the current management of melanoma.
    Oncology (Williston Park) Volume: 23 Page(s): 102 - 104
    01/01/2009 Authors: Delman KA
  • An explosion in the number of centers performing intraperitoneal chemotherapy. Foreword.
    Curr Probl Cancer Volume: 33 Page(s): 123 - 124
    01/01/2009 Authors: Delman KA
  • Percentage of Sentinel Lymph Node Involvement by Metastatic Melanoma as Measured by ACIS Cytometric Image Analysis Is Associated with Survival
    Volume: 89 Page(s): 105A - 105A
    01/01/2009 Authors: Lauer S; Yaar R; Page A; Hestley A; Delman K; Carlson G; Cohen C
  • Percentage of Sentinel Lymph Node Involvement by Metastatic Melanoma as Measured by ACIS Cytometric Image Analysis Is Associated with Survival
    Volume: 22 Page(s): 105A - 105A
    01/01/2009 Authors: Lauer S; Yaar R; Page A; Hestley A; Delman K; Carlson G; Cohen C
  • Regional recurrence after negative sentinel lymph node biopsy for melanoma.
    Ann Surg Volume: 248 Page(s): 378 - 386
    09/01/2008 Authors: Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
  • Changing management and outcome of hepatocellular carcinoma: evaluation of 501 patients treated at a single comprehensive center.
    J Surg Oncol Volume: 98 Page(s): 81 - 88
    08/01/2008 Authors: Kooby DA; Egnatashvili V; Graiser M; Delman KA; Kauh J; Wood WC; Staley Iii CA
  • Therapy for unresectable recurrent and in-transit extremity melanoma.
    Cancer Control Volume: 15 Page(s): 225 - 232
    07/01/2008 Authors: Gimbel MI; Delman KA; Zager JS
  • Epidural analgesia in hepatic resection.
    J Am Coll Surg Volume: 206 Page(s): 1184 - 1192
    06/01/2008 Authors: Page A; Rostad B; Staley CA; Levy JH; Park J; Goodman M; Sarmiento JM; Galloway J; Delman KA; Kooby DA
  • The role of hyperthermia in optimizing tumor response to regional therapy.
    Int J Hyperthermia Volume: 24 Page(s): 251 - 261
    05/01/2008 Authors: Moyer HR; Delman KA
  • Long term follow-up of sentinel lymph node biopsy in atypical spitzoid melanocytic neoplasms
    Volume: 15 Page(s): 18 - 18
    02/01/2008 Authors: Ghazi B; Carlson G; Durham M; Rapkin L; Murray D; Lawson D; Hestley A; Gow K; Kooby D; Staley C
  • Clinical significance of morphometric measurements of melanoma metastatic to single sentinel lymph nodes
    Volume: 88 Page(s): 104A - 104A
    01/01/2008 Authors: Yaar R; Page A; Hestley A; Delman K; Carlson GW; Cohen C
  • Vacuum-assisted closure for surgical wounds in sarcoma.
    J Surg Oncol Volume: 96 Page(s): 545 - 546
    12/01/2007 Authors: Delman KA; Johnstone PAS
  • National surgical patterns of care: regional lymphadenectomy of breast sarcomas.
    Am J Clin Oncol Volume: 30 Page(s): 461 - 465
    10/01/2007 Authors: Gullett NP; Delman K; Folpe AL; Johnstone PAS
  • Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Am Surg Volume: 73 Page(s): 674 - 678
    07/01/2007 Authors: Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
  • Diabetes mellitus is associated with reduced survival after resection for pancreatic ductal adenocarcinoma
    Volume: 132 Page(s): A841 - A841
    04/01/2007 Authors: Egnatashvili V; Yezhelyev M; Delman K; Staley C; Kooby D
  • Routine staging of asymptomatic patients with ulcerated T3 and T4 primary melanomas does not detect distant metastases
    Volume: 14 Page(s): 113 - 114
    02/01/2007 Authors: Schwartz J; Murray DR; Lawson DH; Kooby DA; Staley CA; Rizzo M; Hestley A; Carlson GW; Delman KA
  • Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.
    World J Surg Volume: 30 Page(s): 665 - 669
    05/01/2006 Authors: Delman KA; Shapiro SE; Jonasch EW; Lee JE; Curley SA; Evans DB; Perrier ND
  • Despite a decreased incidence of positive sentinel lymph nodes, advanced age is associated with increased incidence of distant recurrences in patients with melanoma
    Volume: 13 Page(s): 63 - 63
    02/01/2006 Authors: Delman KA; Murray DR; Lawson DH; Tighiouart M; Solomon AR; Hestley A; Carlson GW
  • An analysis of regional recurrence after negative sentinel lymph node biopsy for melanoma
    Volume: 13 Page(s): 89 - 90
    02/01/2006 Authors: Page AJ; Carlson GW; Murray DR; Delman KA; Hestley A; Cohen C
  • National surgical patterns of care: Axillary staging of breast sarcomas
    Volume: 66 Page(s): S718 - S719
    01/01/2006 Authors: Poynter N; Delman K; Folpe AL; Johnstone PA
  • Autoimmune pancreatitis: unveiling a hidden entity.
    Arch Surg Volume: 140 Page(s): 1104 - 1107
    11/01/2005 Authors: Wayne M; Delman KA; Kurt T; Grossi R; Sabatini M; Cooperman A
  • Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
    Liver Transpl Volume: 11 Page(s): 1086 - 1092
    09/01/2005 Authors: Pawlik TM; Delman KA; Vauthey J-N; Nagorney DM; Ng IO-L; Ikai I; Yamaoka Y; Belghiti J; Lauwers GY; Poon RT
  • Melanoma metastases to cervical lymph nodes: Extent of involvement following detection by sentinel node biopsy versus clinical examination
    Volume: 12 Page(s): S95 - S95
    02/01/2005 Authors: Delman KA; McClain DM; Schacherer CW; Cormier JN; Gershenwald JE; Mansfield PF; Prieto VG; Diwan AH; Ross MI; Lee JE
  • Effect of murine liver cell proliferation on herpes viral behavior: implications for oncolytic viral therapy.
    Hepatology Volume: 39 Page(s): 1525 - 1532
    06/01/2004 Authors: Delman KA; Zager JS; Bhargava A; Petrowsky H; Malhotra S; Ebright MI; Bennett JJ; Gusani NJ; Kooby DA; Roberts GD
  • Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).
    FASEB J Volume: 18 Page(s): 1001 - 1003
    06/01/2004 Authors: Bennett JJ; Adusumilli P; Petrowsky H; Burt BM; Roberts G; Delman KA; Zager JS; Chou T-C; Fong Y
  • Surgical management of melanoma patients with epitrochlear or popliteal lymph node metastases
    Volume: 11 Page(s): S78 - S78
    02/01/2004 Authors: Delman KA; Cormier JN; Ross MI; Gershenwald JE; Lee JE; Mansfield PF
  • Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver.
    Br J Surg Volume: 90 Page(s): 1225 - 1231
    10/01/2003 Authors: Zager JS; Delman KA; Ebright MI; Malhotra S; Larson S; Fong Y
  • Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Cancer Gene Ther Volume: 10 Page(s): 215 - 223
    03/01/2003 Authors: Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M
  • Multiple administration of NV1020, an oncolytic HSV-1, results in increased anti-tumor efficacy in rodents with colorectal metastases to liver
    Volume: 10 Page(s): S17 - S17
    01/01/2003 Authors: Horsburgh BC; Fong Y; Malhotra S; Delman K; Rogers T; Peterkin JJ; Tufaro F
  • Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.
    Cancer Gene Ther Volume: 9 Page(s): 935 - 945
    11/01/2002 Authors: Bennett JJ; Delman KA; Burt BM; Mariotti A; Malhotra S; Zager J; Petrowsky H; Mastorides S; Federoff H; Fong Y
  • Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.
    Ann Surg Volume: 236 Page(s): 337 - 342
    09/01/2002 Authors: Delman KA; Zager JS; Bennett JJ; Malhotra S; Ebright MI; McAuliffe PF; Halterman MW; Federoff HJ; Fong Y
  • Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model.
    J Thorac Cardiovasc Surg Volume: 124 Page(s): 123 - 129
    07/01/2002 Authors: Ebright MI; Zager JS; Malhotra S; Delman KA; Weigel TL; Rusch VW; Fong Y
  • Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
    Mol Med Volume: 7 Page(s): 561 - 568
    08/01/2001 Authors: Zager JS; Delman KA; Malhotra S; Ebright MI; Bennett JJ; Kates T; Halterman M; Federoff H; Fong Y
  • Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
    J Virol Volume: 75 Page(s): 7050 - 7058
    08/01/2001 Authors: Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ
  • Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
    Ann Surg Volume: 233 Page(s): 819 - 826
    06/01/2001 Authors: Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
  • Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy.
    Hum Gene Ther Volume: 11 Page(s): 2465 - 2472
    12/10/2000 Authors: Delman KA; Bennett JJ; Zager JS; Burt BM; McAuliffe PF; Petrowsky H; Kooby DA; Hawkins WG; Horsburgh BC; Johnson P
  • Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance.
    Surgery Volume: 128 Page(s): 213 - 218
    08/01/2000 Authors: Karpoff HM; Jarnagin W; Delman K; Fong Y
  • Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.
    Ann Surg Volume: 231 Page(s): 762 - 771
    05/01/2000 Authors: Jarnagin WR; Delman K; Kooby D; Mastorides S; Zager J; Brennan MF; Blumgart LH; Federoff H; Fong Y
  • Efficacy of regional vs. systemic viral therapy for peritoneal cancer.
    FASEB JOURNAL Volume: 14 Page(s): A470 - A470
    03/15/2000 Authors: Bennett J; Delman K; Burt B; Mariotti A; Johnson P; Fong Y
  • A quantitative assessment of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging.
    Magn Reson Imaging Volume: 18 Page(s): 181 - 187
    02/01/2000 Authors: Zakian KL; D'Angelica M; Matei C; Yoo HH; Ercolani M; Delman K; Fong Y; Koutcher JA
  • Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses.
    J Gastrointest Surg Volume: 4 Page(s): 580 - 588
    01/01/2000 Authors: McAuliffe PF; Jarnagin WR; Johnson P; Delman KA; Federoff H; Fong Y
  • Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer.
    J Mol Med (Berl) Volume: 78 Page(s): 166 - 174
    01/01/2000 Authors: Bennett JJ; Kooby DA; Delman K; McAuliffe P; Halterman MW; Federoff H; Fong Y
  • Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.
    Mol Med Volume: 5 Page(s): 606 - 616
    09/01/1999 Authors: D'Angelica M; Tung C; Allen P; Halterman M; Delman K; Delohery T; Klimstra D; Brownlee M; Federoff H; Fong Y
  • Resuscitation with lactated Ringer's solution after hemorrhage: lack of cardiac toxicity.
    Shock Volume: 5 Page(s): 298 - 303
    04/01/1996 Authors: Delman K; Malek SK; Bundz S; Abumrad NN; Lang CH; Molina PE
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements